A Phase II trial comparing Brivudin 0.1% ophthalmic solution with Aciclovir 3 % ophthalmic ointment in the treatment of patients with herpetic dendritic keratitis.

Trial Profile

A Phase II trial comparing Brivudin 0.1% ophthalmic solution with Aciclovir 3 % ophthalmic ointment in the treatment of patients with herpetic dendritic keratitis.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 13 Apr 2013

At a glance

  • Drugs Aciclovir (Primary) ; Brivudine (Primary)
  • Indications Dendritic keratitis
  • Focus Therapeutic Use
  • Sponsors Menarini Ricerche
  • Most Recent Events

    • 23 Jun 2012 Additional location (Spain) added as reported by European Clinical Trials Database.
    • 09 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top